Micellar Palladium-Catalyzed Aqueous Sonogashira Coupling with Amphiphilic Polymer PEG–PVEG
Organic Letters · 11.11.2026
DOI: 10.1021/acs.orglett.6c04484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 11.11.2026. Verfasst von Lili Ji und 6 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
An efficient, copper-free, palladium-catalyzed aqueous Sonogashira reaction has been developed, enabled by the self-assembly of the amphiphilic copolymer polyethylene glycol-polyvinylethylene glycol (PEG–PVEG). Using 0.02 mol % of CataCXium A Pd G3 as the catalyst under mild conditions, this aqueous micellar system accommodates a broad range of (hetero)aryl bromides and chlorides, affording the corresponding substituted alkynes in high efficiency with excellent functional group tolerance. The synthetic utility of this system was demonstrated by the successful preparation of pharmaceutical intermediates and indole derivatives. Notably, this protocol exhibited high in-flask recyclability with the reaction medium remaining effective for at least four consecutive runs.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ji, L., Li, J., Chai, Q., Shah, B. H., Khan, S., Li, M., & Zhang, Y. J. (2026). Micellar Palladium-Catalyzed Aqueous Sonogashira Coupling with Amphiphilic Polymer PEG–PVEG. Organic Letters. https://doi.org/10.1021/acs.orglett.6c04484
Vancouver
Ji L, Li J, Chai Q, Shah BH, Khan S, Li M, et al. Micellar Palladium-Catalyzed Aqueous Sonogashira Coupling with Amphiphilic Polymer PEG–PVEG. Organic Letters. 2026. doi:10.1021/acs.orglett.6c04484
BibTeX
@article{Ji2026,
author = {Ji, Lili and Li, Jingan and Chai, Qiong and Shah, Babar Hussain and Khan, Sardaraz and Li, Meiqi and Zhang, Yong Jian},
title = {Micellar Palladium-Catalyzed Aqueous Sonogashira Coupling with Amphiphilic Polymer PEG–PVEG},
journal = {Organic Letters},
year = {2026},
doi = {10.1021/acs.orglett.6c04484}
}
EUVIMED